↓ Skip to main content

Direct oral anticoagulants in pediatric venous thromboembolism: Review of approved products rivaroxaban and dabigatran

Overview of attention for article published in Frontiers in Pediatrics, October 2022
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (62nd percentile)
  • High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

policy
1 policy source

Citations

dimensions_citation
7 Dimensions

Readers on

mendeley
19 Mendeley